Edition:
United States

Retrophin Inc (RTRX.O)

RTRX.O on Consolidated Issue listed on NASDAQ Global Market

24.23USD
19 Mar 2019
Change (% chg)

$0.27 (+1.13%)
Prev Close
$23.96
Open
$24.02
Day's High
$24.69
Day's Low
$24.02
Volume
542,086
Avg. Vol
362,682
52-wk High
$33.00
52-wk Low
$19.77

Chart for

About

Retrophin, Inc. is a biopharmaceutical company. The Company is focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic or rare diseases. The Company sells three products, including Chenodal (chenodeoxycholic acid), Cholbam (cholic acid) and Thiola (tiopronin). Its... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $948.89
Shares Outstanding(Mil.): 38.39
Dividend: --
Yield (%): --

Financials

  RTRX.O Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -1.86 -- --
ROI: -15.89 8.89 13.82
ROE: -22.95 10.00 15.25

Earnings vs. Estimates